Showing 26,341 - 26,360 results of 55,503 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (largest decrease)) ))', query time: 1.16s Refine Results
  1. 26341
  2. 26342

    Table_1_Effects of Oral Carotenoids on Oxidative Stress: A Systematic Review and Meta-Analysis of Studies in the Recent 20 Years.pdf by Chengfei Zhuang (12468015)

    Published 2022
    “…The meta-analysis results showed that carotenoids complex supplementation significantly increased the levels of antioxidative parameters ferric-reducing ability of plasma (FRAP) and oxygen radical absorbance capacity (ORAC) [standardized mean difference (SMD) = 0.468; 95% CI: 0.159–0.776, p = 0.003; SMD = 0.568; 95% CI: 0.190–0.947, p = 0.003] and decreased the blood triglyceride (TG) level (SMD = −0.410, 95% CI: −0.698 to −0.122, p = 0.005). …”
  3. 26343

    Data_Sheet_1_The Positive Effects of Cancer Survivor Support Service on Distress in South Korea: A Nationwide Prospective Study.docx by Hyun Jeong Lee (1993561)

    Published 2022
    “…</p>Results<p>This study included 1,921 cancer survivors, with a mean age of 57.3 years (68.7% females). Breast cancer was most common, followed by stomach and colorectal cancer. …”
  4. 26344

    Functional effects of 10E8 on HIV-1 clade C variants including those with a naturally occurring L673 residue. by Arthur S. Kim (603570)

    Published 2014
    “…Purple highlight shows when neutralization potency is decreased by greater than three-fold and gold highlight shows when neutralization potency is increased greater than three-fold. …”
  5. 26345

    Table1_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  6. 26346

    Image_1_Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study.TIF by Eike Steidl (3607406)

    Published 2022
    “…These patients also showed significantly decreased FA and increased MD.</p>Conclusion<p>While the rater-based approach yielded the best performance on T2 imaging, a quantitative, more sensitive HOD diagnosis based on ION intensities in PD and DTI imaging seems possible.…”
  7. 26347

    Image3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  8. 26348

    Table4_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  9. 26349

    Table2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  10. 26350

    Data Sheet 1_Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study.pdf by Sam Salek (5800727)

    Published 2025
    “…Background<p>Disease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.…”
  11. 26351

    Table3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  12. 26352

    Data Sheet 2_Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study.docx by Sam Salek (5800727)

    Published 2025
    “…Background<p>Disease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.…”
  13. 26353

    Neurogenesis in 12-month-old AβPP-PS1 and wild-type mice on control and specific multi-nutrient diets. by Diane Jansen (414816)

    Published 2013
    “…Post hoc analysis revealed that AβPP-PS1 mice fed the CO diet displayed a significantly decreased relative amount of Dcx+ immature neurons compared to wild-type mice on the CO diet (*<i>p</i> = 0.004). …”
  14. 26354

    Data_Sheet_1_Extramatrical Mycelium and Ectomycorrhizal Community Composition of Quercus pubescens in a Sub-Mediterranean Stress-Prone Environment.PDF by Tanja Mrak (8541582)

    Published 2021
    “…This was ascribed to a series of stress events that occurred at the site including sequential droughts and wildfire. …”
  15. 26355

    Image2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  16. 26356

    Image1_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  17. 26357

    DataSheet_1_The Efficacy of Denosumab in Patients With Rheumatoid Arthritis: A Systematic Review and Pooled Analysis of Randomized or Matched Data.docx by Qiongwen Hu (11904590)

    Published 2022
    “…</p>Results<p>After searching the literature and performing further detailed assessments, 10 studies with a total of 1758 patients were included in the quantitative analysis. …”
  18. 26358

    The effect of green tea supplementation on the anthropometric outcomes in overweight and obese women: a time and dose-response meta-analysis of randomized controlled trials by Yiyi Zhang (164519)

    Published 2023
    “…In subgroup analyses, GT consumption demonstrated lowered body weight with dosaes ≥1000 mg/day (WMD: −1.38 kg), in the RCTs, which lasted ≥8 wk (WMD: −1.24 kg). The non-linear dose-response assessment detected a negative correlation between the changes in body weight and BMI in green tea consumption of more than 1000 (mg/day). …”
  19. 26359

    Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis by Vasudha Ahuja (9982448)

    Published 2021
    “…Prescreening with a diabetes-specific risk calculator to identify high-risk individuals is suggested to decrease the proportion of false-positive cases. …”
  20. 26360

    Data_Sheet_1_The Onset and Solidification Path of a Basaltic Melt by in situ Differential Scanning Calorimetry (DSC) and ex situ Investigations.docx by Letizia Giuliani (842482)

    Published 2020
    “…The increment of ΔT/Δt causes an increase of the CSD slope (m) and crystal population density per size (n<sub>0</sub>), as well as a decrease of the crystal size, for both cpx and sp. …”